Amrita QezthaniChief Operating Officer

Speaking & conversations

Discuss the work that a headline production result leaves out

01

Where the promise waits after the press has finished

Forty-minute production and capital discussion · Manufacturing executives, finance leaders and directors

This proposed session follows a leaflet route through printing and folding to examine where an investment could change completed work. The fictional demand mix contains twenty-four million monthly leaflets: six million flat and eighteen million folded, against sixteen million folding capability. Participants consider why a busy printing department did not by itself justify the proposed additional press. The discussion retains the different scopes and prices of the ₹6.4 crore press and ₹3.8 crore folding programme. It then distinguishes the installed twenty-million rating from 17.2 million actually completed in a specified review month. The purpose is to help an executive audience ask how the route, job mix and remaining conditions support a capital proposal. It does not prescribe an equipment choice for a real factory or claim that commissioning an asset proves its operating result. Participants leave with questions about the next process and the evidence still needed after an investment has been approved, rather than a universal production formula.

02

Two delivery percentages, one unfinished customer obligation

Forty-five-minute case workshop · COOs, commercial heads and performance-reporting teams

The session examines a cohort of 120 orders containing thirty million leaflets. Ninety-six orders were on time, but they represented only fourteen million units; the twenty-four late orders held sixteen million. Participants compare the 80% order result with the approximately 46.7% quantity result and discuss why neither should silently replace the other. The original agreed dates remain fixed throughout the exercise. We consider how small urgent orders, large delayed jobs and the concentration of customer exposure can require different questions from the same dataset. The intended contribution is a more careful operating conversation about units, distribution and commitments, not a new percentage selected to make management appear stricter. Correcting the report does not itself improve delivery, and the case includes no invented recovery result. The workshop is designed for an audience able to discuss its reporting choices without sharing confidential customer records, with enough time to test where a valid measure can still leave an important consequence unseen.

03

A partial release needs a complete account of its boundaries

Thirty-five-minute supplier-leadership conversation · Specialist suppliers, quality leaders and customer-operations teams

This proposed conversation uses an eighteen-language leaflet programme to examine the difference between an urgent request and the approvals inside it. Fourteen layouts covering 2.1 million units were ready, while four covering 900,000 remained pending. The customer agreed a partial release, followed later by the remaining quantity, with ₹28 lakh of additional expediting expense. Participants follow the negotiation of scope, quantity and cost without asking the printer to approve pharmaceutical wording or translations. The discussion asks how a supplier can be useful when it does not own every decision needed for delivery, and how the pending work should remain visible after the first dispatch. It is an operating-leadership example, not guidance for releasing an actual medicine or certifying clinical content. The audience should leave with a clearer way to discuss who can authorise what, which part can proceed and what the changed sequence costs, while recognising that the particular contract and professional responsibilities still determine the real decision.

04

The extra pallet spaces belong in the operating decision

Forty-minute packaging-economics case discussion · Operations, logistics and capital-allocation leaders

Participants examine a 600-carton shipping format that requires fifteen pallets at forty cartons per pallet and twenty pallets at thirty cartons. The five additional spaces cost ₹5,500 per shipment at the fictional ₹1,100 rate, creating a ₹5.5 lakh quarterly allowance for a hundred shipments. The case connects that arithmetic with a packaging trial in which thirty-eight of forty-two shipments met the agreed conditions and four remained unresolved. We discuss why the additional expense, the scope of the trial and the unresolved results all belong in the same operating account. The session does not claim that a lower stack prevents every form of damage or provides a universal packing specification. Its purpose is to help leaders connect a physically tested arrangement with the cost they are asking the enterprise to accept. A useful discussion preserves the reasons to proceed under reviewed conditions while retaining the evidence that could require the arrangement to change again.

Short speaker biography

Amrita Qezthani is a fictional Belagavi COO whose thirty-year career connects prepress, printing and folding with the component a customer can use. Her illustrative cases examine a failed layout, a changed capital proposal, unequal delivery measures and bounded releases. She holds no statutory directorship and does not approve pharmaceutical content.

Standard speaker biography

Amrita Qezthani is the fictional COO of Nevqumi Printed Healthcare Components, a Belagavi and Hubballi leaflet printer serving 34 pharmaceutical customers. She leads 290 operations colleagues through six heads with ₹72 crore annual operating expense. Her thirty-year career began in prepress after a printing degree and developed through production, plant and multi-site management. The examples on this website retain an owned layout error, a folding investment, a delivery-report correction and the costs of revised release and packing arrangements. She has presented operating matters to a board but has no statutory appointment. Her proposed sessions explore production judgement and its boundaries; they do not certify products, approve pharmaceutical wording or imply that the fictional events are real speaking engagements.

Extended speaker biography

Amrita Qezthani is a fictional operations leader based in Belagavi. She is presented as COO of Nevqumi Printed Healthcare Components, an invented business with two plants, 510 employees and 34 pharmaceutical customers. She leads 290 operations colleagues through six heads with ₹72 crore annual operating expense. The company's FY ending March 2026 revenue of ₹184 crore and operating profit of ₹16.2 crore describe enterprise scale, rather than results attributed solely to her team. Her career began in August 1996 after a printing degree and progressed through prepress coordination, production management, a specialist plant and multi-site operations. The profile includes a sheet-layout decision she got wrong, an investment redirected from printing to folding, delivery measures viewed by both orders and units, a partial language release and a more expensive pallet arrangement with unresolved trial results. Those examples preserve the cost and limits of the decisions. She does not approve clinical language, translations or finished medicines. She has no statutory directorship; the fictional record includes July 2026 IICA registration with the assessment unfinished and no exemption. Proposed board and speaking interests remain subject to relationships, preparation and practical capacity. Every identity, business and engagement described here is illustrative, allowing a prospective leader to see how a complete operating narrative can explain judgement without inventing unrestricted authority or unmeasured success.

An invitation

Contact

I would consider one first board appointment in specialised converting or a manufacturing supply chain. I hold no statutory seat. This fictional record includes July 2026 IICA registration with the assessment unfinished and no exemption. Twenty-four provisional days, employer consent and relationship review would be prerequisites to exploring a suitable contribution.

Open to
  • Board appointments
  • Advisory roles
  • Speaking invitations

office@amritaqezthani.example